2.1
Vibegron (Obgemsa, Pierre Fabre) is indicated 'in symptomatic treatment of adult patients with overactive bladder (OAB) syndrome'.
Vibegron (Obgemsa, Pierre Fabre) is indicated 'in symptomatic treatment of adult patients with overactive bladder (OAB) syndrome'.
The dosage schedule is available in the summary of product characteristics for vibegron.
The list price of vibegron is £26.68 per pack of 30 tablets (excluding VAT; company submission July 2024).